INSIGHTS ON DRUG DEVELOPMENT
-
An All-In-One Solution For Residual DNA Quantitation
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
Accelerate FDA Approval With Fast Track Designation
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
Don't Let Your Filling Equipment Dictate Your Drug Formulation
Gravimetric powder dosing measures true mass to eliminate equipment-driven reformulation, preserving particle design and speeding clinical development.
-
Complementing Routine Peptide Monitoring7/29/2025
Discover how to enhance your peptide analysis by integrating UV and mass spectral data into a single, streamlined workflow to boost data confidence and lab efficiency.
-
The Work That Never Shows Up In Your QA Plan4/29/2026
Manual audit prep consumes valuable quality capacity. Transitioning to continuous readiness automates evidence generation and scales compliance efficiently.
-
Complementary Methodologies For Analysis Of NISTmAb Impurities2/27/2026
Gain insight into how SEC and CE‑SDS complement each other to assess monoclonal antibody size variants, offering stronger insight into aggregates, fragments, and overall purity.
-
Compaction Simulation For Tablet Technology Transfer And Scale-Up7/15/2026
Compaction simulation de-risked tech transfer for a 40 mg fexuprazan tablet by defining optimal roller compaction and lubrication parameters before scale-up. Access the full case study to see the data.
-
Together, Let's Sail Toward Success7/23/2025
Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.
DRUG DEVELOPMENT SOLUTIONS
-
The systems can be provided in sterile, toxic or sterile toxic arrangements with the great advantage of being 100 % scalable.
-
Explore immunoassays and LC-MS kits for over 30 clinical areas, each with detailed specifications and broad sample compatibility for precise, high-throughput biomarker analysis.
-
Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.
-
STELLARIS 5 Cryo Confocal Light Microscope
The STELLARIS 5 Cryo is a confocal light microscope system that helps you to target your area of interest for cryo-electron tomography (CryoET). The STELLARIS 5 Cryo gives you the precision to target reliably, while still offering superior performance you can count on and improved productivity for your experiments.
-
THUNDER Imager EM Cryo CLEM
In-depth understanding of cellular structural biology
The THUNDER Imager EM Cryo CLEM is a cryo light microscope featuring opto-digital THUNDER technology. It provides the imaging data and secure cryo conditions you need for successful experimental investigations concerning structural biology. Precisely identify cellular structures of interest thanks to high resolution, haze-free imaging with THUNDER technology, then transfer the specimen seamlessly to your EM.